Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology

Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology

A suitable diagnostic classification of myeloid neoplasms and acute leukemias requires testing for a large number of molecular biomarkers. Next-generation sequencing is a technology able to integrate identification of the vast majority of them in a single test. This manuscript includes the design, a...

Full description

Bibliographic Details
Main Authors: Bilbao, C. (Author), Calabria, I. (Author), Carbonell, P. (Author), Carrillo-Cruz, E. (Author), Gargallo, P. (Author), Gómez, I. (Author), Hermosín, L. (Author), Izquierdo-García, M. (Author), Jiménez-Velasco, A. (Author), Lázaro, M. (Author), Molero, M. (Author), Pérez-López, O. (Author), Ruiz, C. (Author), Soria, E. (Author), Stuckey, R. (Author), Such, E. (Author), Valero-García, J. (Author), Yáñez, Y. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
acute lymphoblastic leukemia
acute myeloid leukemia
myelodysplastic syndrome
myeloid neoplasms with germline predisposition
myeloproliferative neoplasms
NGS panel
targeted capture sequencing
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items